EUCTR2005-000129-47-SE进行中（未招募）不适用
The effect of Adalimumab (Humira) on vascular abnormalities in rheumatoid arthritis. A pilot study.
Dept. of Rhematology UMAS0 个研究点目标入组 15 人开始时间: 2005年2月25日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with rheumatoid arthritis wich are planned to be treated with adalimumab (Humira) because of severe disease activity.Previously nonresponder on one DMARD. At the time of inclusion at least 6 swollen joints in 28-joint index protocoll and CRP more than 8 mg/L.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Anti-TNF treatment for the last three months.
- •Highdose peroral cortison (>= 20 mg daily) or has been treated with intravenous cortison two weeks before inclusion.
研究者
相似试验
已完成
4 期
The Effect of Adalimumab (Humira) on Vascular Abnormalities in Rheumatoid Arthritis. A Pilot Study.Rheumatoid ArthritisNCT01270087Skane University Hospital14
进行中（未招募）
不适用
THE ANTI-ANGIOGENIC EFFECTS OF ADALIMUMAB INCROHN`S DISEASE - NDCrohn`s DiseaseMedDRA version: 9.1Level: LLTClassification code 10038283Term: Regional enteritis of small intestine with large intestineEUCTR2009-011763-37-ITISTITUTO CLINICO HUMANITAS
进行中（未招募）
1 期
Der Einfluss von Adalimumab auf kardiovaskuläre und metabolische Risikofaktoren in der Therapie von Patienten mit mittelschwerer bis schwerer Psoriasis vulgaris im Vergleich zu einer Standardtherapie (Fumarsäureester) - CASTIP(Comorbidities and systemic therapies in psoriasis)MedDRA version: 12.1Level: LLTClassification code 10050576Term: Psoriasis vulgarisPsoriasis vulgarisEUCTR2010-018369-48-ATMedizinische Universität Wien66
已完成
4 期
Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Severe Plaque PsoriasisPsoriasisVascular InflammationCoronary AtherosclerosisNCT00940862Innovaderm Research Inc.30
已完成
3 期
Efficacy of MabAsia (Adalimumab) in Rheumatoid ArthritisRheumatoid Arthritis.Seropositive Rheumatoid ArthritisIRCT2014090319025N1Vice Chancellor for research, Tehran University of Medical Sciences105